microscopic colitis: Inflammation of the colon that is only apparent by microscopic examination.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
189 |
4. Check minimum number of eventsNone |
189 |
5. Include endpointsNone |
189 |
6. Filter based on genotype QC (FinnGen only) |
189 |
Control definitions (FinnGen only)
- Control exclude
- M13_NECROVASC
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M31
Similar endpoints
↥List of similar endpoints to
Microscopic polyangiitis
based on the number of shared cases.
Similar with more cases:
- Other necrotizing vasculopathies (FG)
- Other necrotizing vasculopathies
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Finngen Rheumatological endpoints
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 813 | 470 | 342 |
| Only index persons | 808 | 467 | 341 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 68.31 | 67.54 | 69.40 |
| Only index persons | 68.35 | 67.57 | 69.42 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 189 | 111 | 78 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | 66.40 | 65.55 | 67.60 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 171
- Matched controls
- 1710
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M31.7
ICD-10 Finland
Microscopic polyangiitis
+∞
164.1
130
*
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
123.3
103
*
L04AX01
ATC
azathioprine; systemic
98.0
98.6
105
27
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
+∞
75.8
67
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
171.3
71.5
71
7
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
19.8
58.5
100
113
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
42.5
39
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
20.9
39.1
60
43
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
39.1
36
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
51.8
39.0
46
12
L04AA06
ATC
mycophenolic acid; systemic
71.1
38.5
43
8
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
51.6
36.4
43
11
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
32.3
30
*
H02AB06
ATC
prednisolone; systemic
7.7
30.4
138
600
TK800
NOMESCO Finland
Hemodialysis
54.5
30.0
35
8
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.9
29.9
123
464
N17.9
ICD-10 Finland
Acute renal failure, unspecified
21.0
28.1
42
26
Z49.1
ICD-10 Finland
Extracorporeal dialysis
90.1
27.8
30
*
B03XA02
ATC
darbepoetin alfa; parenteral
53.6
26.6
31
7
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
+∞
25.7
24
*
N18.8
ICD-10 Finland
Other chronic renal failure
21.4
24.4
36
21
A11CC03
ATC
alfacalcidol; systemic
34.0
24.2
31
11
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
63.6
23.8
27
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.6
23.8
126
570
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.7
22.5
81
233
H02AB04
ATC
methylprednisolone; systemic
6.5
22.0
66
150
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
15.4
21.0
35
28
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.9
20.5
43
56
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
11.2
20.0
39
44
N085, M318
ICD-10 Finland
NA
+∞
19.1
18
*
C03CA01
ATC
furosemide; systemic
4.6
19.0
93
353
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.0
18.9
59
138
M05BA04
ATC
alendronic acid; oral
7.3
18.3
47
84
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
8.4
18.1
42
64
N18.0
ICD-10 Finland
End-stage renal disease
41.7
18.1
22
6
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.3
17.9
36
43
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
100.0
16.9
18
*
TGC00
NOMESCO Finland
Bronchial lavation
16.8
16.5
26
18
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.0
15.8
47
101
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
9.0
15.3
33
44
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
13.7
15.2
26
22
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.8
15.2
40
73
Z94.0
ICD-10 Finland
Kidney transplant status
87.8
14.8
16
*
ZX120
NOMESCO Finland
Intravenous
6.1
14.8
43
89
ZX108
NOMESCO Finland
Inhalation
39.9
14.8
18
5
L01AA01
ATC
cyclophosphamide; systemic
+∞
13.7
13
*
A02BC02
ATC
pantoprazole; systemic
4.1
13.5
140
901
N08.5*M31.0
ICD-10 Finland
Glomerular disorders in Goodpasture's syndrome
+∞
12.7
12
*
N08.5*M30.0
ICD-10 Finland
Glomerular disorders in polyarteritis nodosa
+∞
12.7
12
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
139.8
12.6
13
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
29.2
12.3
16
6
A12AA04
ATC
calcium carbonate; oral
29.2
12.3
16
6
N19
ICD-10 Finland
Unspecified kidney failure
9.3
12.1
25
31
R50.9
ICD-10 Finland
Fever, unspecified
4.6
12.0
45
123
KA1AE
NOMESCO Finland
Kidney ultrasound examination
15.1
11.8
19
14
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
10.0
11.7
23
26
N08.5*M31.1
ICD-10 Finland
Glomerular disorders in thrombotic thrombocytopenic purpura
+∞
11.6
11
*
WW400
NOMESCO Finland
Plasmaferesis
128.3
11.6
12
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
128.3
11.6
12
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
27.2
11.3
15
6
127
Kela drug reimbursment
Transplant complication
27.2
11.3
15
6
C08CA01
ATC
amlodipine; oral
3.1
11.0
92
470
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
7.5
11.0
26
40
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
42.8
10.1
12
*
GD1AD
NOMESCO Finland
Thorax CT examination
8.0
9.9
22
31
137
Kela drug reimbursment
Uraemia requiring dialysis
58.4
9.8
11
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.5
9.7
29
61
N17.8
ICD-10 Finland
Other acute renal failure
16.3
9.7
15
10
R04.2
ICD-10 Finland
Haemoptysis
9.6
9.6
19
22
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
10.4
9.5
18
19
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
+∞
9.5
9
*
M30.0
ICD-10 Finland
Polyarteritis nodosa
+∞
9.5
9
*
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
+∞
9.5
9
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
5.6
9.3
27
55
205
Kela drug reimbursment
Chronic hypertension
2.9
8.9
71
338
J01MA14
ATC
moxifloxacin; systemic
4.5
8.9
32
83
B03XA01
ATC
erythropoietin; parenteral
52.8
8.8
10
*
J01MA12
ATC
levofloxacin; systemic
3.2
8.7
51
200
D64.9
ICD-10 Finland
Anaemia, unspecified
4.2
8.7
34
96
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
8.6
57
242
H26.3
ICD-10 Finland
Drug-induced cataract
94.5
8.5
9
*
V03AE02
ATC
sevelamer; oral
+∞
8.4
8
*
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
8.4
8
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
8.4
8
*
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
+∞
8.4
8
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
8.4
8
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.2
8.4
32
88
PAW37
NOMESCO Finland
Biopsy of temporal artery
47.2
7.8
9
*
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
47.2
7.8
9
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.3
7.6
28
74
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.8
7.5
56
254
1AA01
NOMESCO Finland
NA
83.6
7.5
8
*
Z49.2
ICD-10 Finland
Other dialysis
83.6
7.5
8
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
83.6
7.5
8
*
R31
ICD-10 Finland
Unspecified haematuria
4.0
7.4
30
87
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.7
7.3
32
99
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
7.3
7
*
GD1UN
NOMESCO Finland
Lung circulation SPECT
+∞
7.3
7
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
7.2
44
176
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.0
7.0
45
183
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.9
6.8
16
25
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
41.8
6.8
8
*
B05DA
ATC
Isotonic solutions
41.8
6.8
8
*
B05DB
ATC
Hypertonic solutions
41.8
6.8
8
*
C08CA13
ATC
lercanidipine; oral
3.3
6.7
36
128
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.8
6.6
44
186
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.9
6.5
26
75
GD2SN
NOMESCO Finland
Lung ventilation SPECT
72.4
6.5
7
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
+∞
6.3
6
*
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
+∞
6.3
6
*
D638, N188
ICD-10 Finland
NA
+∞
6.3
6
*
J01CA04
ATC
amoxicillin; systemic
2.8
6.3
146
1158
J47
ICD-10 Finland
Bronchiectasis
8.2
6.2
13
17
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.3
6.2
32
113
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
116
44
66.67
182.88
17.1
1.2
20.7
—
iu/ml
—
89
0
87
28
56.72
141.37
4.0
1.1
254.5
—
titre
—
11
0
53
13
56.27
90.31
2.1
1.1
—
—
u/ml
—
0
0
112
230
10.50
60.77
6.3
2.3
23.6
21.6
%
0.92
104
193
46
31
19.29
53.82
6.6
7.6
547.8
156.6
iu/ml
—
11
5
164
619
13.47
47.14
20.2
3.2
—
—
—
0
0
121
362
7.51
42.81
11.5
2.7
2.1
4.6
e6/l
4.73
113
312
81
169
7.64
41.11
13.6
4.7
1.3
1.9
mmol/l
0.70
75
135
46
49
12.09
40.61
1.9
1.5
5.6
0.1
iu/ml
—
6
9
81
171
7.54
40.58
13.6
4.6
5.9
5.8
kpa
0.38
81
166
140
519
7.55
38.19
18.2
4.2
27.0
9.1
mg/mmol
2.53
132
325
159
665
9.76
38.13
4.4
2.4
85.9
77.4
nmol/l
3.42
154
577
168
803
10.83
33.05
20.1
6.0
21.0
27.4
%
12.39
168
748
167
794
10.48
33.02
18.9
5.8
64.9
57.5
%
11.66
167
745
171
841
11.85
32.35
28.5
7.3
1.2
1.2
mmol/l
0.16
152
702
126
489
5.73
30.55
16.6
3.3
0.2
0.6
e6/l
1.98
116
363
34
35
11.63
30.36
1.4
1.7
—
—
—
0
0
36
42
10.35
29.41
2.0
1.7
—
—
—
0
0
38
48
9.66
29.24
1.8
1.5
—
—
—
0
0
64
144
6.21
29.07
1.7
2.5
62.1
66.7
g/l
3.08
53
131
115
431
5.26
28.61
5.4
3.0
386.7
8036.1
umol/l
2.17
108
357
35
41
10.25
28.47
2.0
1.7
—
—
—
0
0
38
50
9.26
28.28
1.3
4.6
79.4
188.1
mg/l
0.39
30
39
38
50
9.26
28.28
1.3
4.6
61.9
34.8
mg/l
2.48
30
39
30
29
12.11
27.85
1.4
1.7
—
—
—
0
0
90
282
5.18
27.82
2.8
1.9
—
—
—
0
0
30
30
11.70
27.21
2.0
1.7
—
—
—
0
0
25
19
15.01
26.78
1.9
1.3
—
—
—
0
0
175
966
11.96
26.70
22.0
9.5
4.9
4.1
e9/l
4.82
168
846
42
67
7.77
26.52
1.1
2.3
31.8
37.4
u/l
0.89
37
60
34
42
9.65
26.51
1.3
1.9
—
—
—
0
0
53
109
6.37
26.23
12.5
4.2
0.7
1.9
mmol/l
1.66
43
85
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
55
8.12
24.78
4.0
3.3
0.4
0.4
u/ml
0.12
23
31
40
69
7.08
23.38
2.6
1.6
0.8
5.4
ug/l
0.58
34
61
87
300
4.52
23.07
11.7
3.0
0.4
1.1
e6/l
2.80
71
174
26
27
11.01
22.86
1.7
1.3
—
—
—
0
0
27
30
10.33
22.64
1.5
1.7
—
—
—
0
0
99
385
4.30
22.11
2.5
2.1
2.9
3.2
mg/l
0.50
85
334
25
26
10.93
21.93
2.1
1.4
—
—
—
0
0
25
26
10.93
21.93
1.5
1.7
—
—
—
0
0
67
202
4.59
20.92
2.3
1.8
—
—
—
0
0
19
14
14.98
20.52
2.2
4.0
—
—
—
0
0
24
26
10.43
20.42
1.8
1.4
246.2
299.1
u/ml
0.16
18
14
22
22
11.19
19.75
1.7
1.5
—
—
—
0
0
77
270
4.13
19.43
13.1
3.2
1.0
2.4
e6/l
1.55
61
146
17
12
15.47
18.72
1.6
1.5
—
—
—
0
0
144
794
4.42
18.36
15.7
4.8
0.0
0.0
estimate
0.00
36
167
64
204
4.23
18.29
2.5
1.9
—
—
—
0
0
143
792
4.31
17.93
11.5
3.6
0.0
0.0
estimate
0.00
34
169
171
1083
7.08
17.90
11.5
4.6
224.8
209.8
e6/l
—
5
20
144
802
4.34
17.90
11.5
3.6
0.0
0.0
estimate
0.00
36
158
21
23
10.15
17.65
1.1
1.1
—
—
—
0
0
22
28
8.76
16.51
6.5
4.1
64.4
57.9
%
1.09
22
28
17
16
11.58
15.77
1.1
1.1
—
—
—
0
0
25
40
7.05
15.44
2.5
1.1
—
—
—
0
0
21
28
8.31
15.15
6.4
3.5
4.6
4.5
e9/l
0.05
21
28
16
15
11.56
14.84
2.9
1.4
471.9
532.2
e6/l
—
16
10
15
13
12.45
14.60
2.1
1.3
—
—
—
0
0
24
39
6.90
14.59
1.6
1.3
4.4
2.4
u/ml
—
8
10
29
60
5.53
13.84
3.5
2.6
—
—
—
0
0
86
390
3.21
13.76
3.8
2.5
—
—
—
0
0
22
35
6.98
13.61
1.3
1.6
—
—
—
0
0
22
35
6.98
13.61
1.3
1.6
—
—
—
0
0
13
10
13.89
13.50
1.8
1.4
—
—
—
0
0
13
10
13.89
13.50
1.8
1.4
—
—
—
0
0
22
36
6.78
13.25
1.5
1.3
—
—
—
0
0
43
130
3.99
12.85
3.0
3.1
46.1
59.6
ml/min/173m2
1.98
23
56
12
0
+∞
12.64
1.2
0.0
—
—
—
0
0
47
153
3.76
12.63
6.2
9.4
1.3
1.4
mmol/l
0.22
47
148
14
14
10.72
12.38
1.9
1.7
—
—
—
0
0
85
402
3.03
12.37
2.0
1.6
18.7
21.4
nmol/l
1.03
79
327
101
531
2.94
12.03
2.3
2.0
158.6
165.7
u/l
0.05
95
498
31
78
4.56
11.74
1.5
1.9
8.3
7.6
g/l
0.97
22
64
31
78
4.56
11.74
1.5
1.9
—
—
—
0
0
31
78
4.56
11.74
1.5
1.9
4.0
3.8
g/l
0.32
21
62
107
586
2.90
11.72
5.4
3.2
2.3
2.4
mmol/l
1.54
99
507
36
102
4.12
11.70
2.7
1.6
—
—
—
0
0
29
71
4.64
11.35
1.5
2.0
3.8
3.3
g/l
1.49
21
63
71
328
2.87
10.48
2.1
1.7
1123.7
1215.9
nmol/l
0.35
61
243
29
76
4.33
10.40
1.5
2.0
11.2
10.6
g/l
0.27
22
69
25
60
4.65
9.99
3.2
2.0
—
—
—
0
0
73
354
2.73
9.70
2.4
1.9
2.9
1.4
mg/l
1.22
65
279
36
118
3.53
9.42
1.8
1.5
—
—
—
0
0
120
752
2.63
9.30
5.3
4.4
—
—
—
0
0
13
7
19.81
9.07
2.7
1.4
—
—
—
0
0
109
658
2.55
9.06
2.6
2.0
97.6
96.2
pmol/l
0.10
64
317
23
56
4.54
9.01
3.1
1.8
—
—
—
0
0
141
965
2.82
9.00
10.9
5.8
6.9
6.7
mmol/l
0.36
136
898
25
66
4.21
8.84
1.6
2.0
31.3
37.1
g/l
2.57
19
59
21
49
4.70
8.65
1.4
1.3
—
—
—
0
0
25
69
4.02
8.33
1.6
2.3
0.1
0.5
g/l
0.98
20
61
47
197
2.84
8.09
6.2
11.4
4.9
5.2
kpa
2.01
47
190
11
14
8.28
8.07
1.2
1.2
—
—
—
0
0
28
86
3.65
8.03
6.8
2.7
0.7
0.7
%
0.04
28
86
28
87
3.60
7.89
6.8
2.7
1.1
1.1
%
0.07
28
87
56
265
2.58
7.56
1.4
1.3
103.0
41.5
iu/ml
0.86
18
87
7
0
+∞
7.33
1.1
0.0
—
—
—
0
0
45
199
2.66
6.91
6.5
11.3
0.3
1.5
mmol/l
1.37
39
166
52
247
2.52
6.91
1.4
1.3
24.5
13.7
u/ml
0.30
22
88
11
17
6.81
6.85
1.7
1.4
—
—
—
0
0
11
17
6.81
6.85
1.7
1.4
—
—
—
0
0
11
17
6.81
6.85
1.7
1.4
—
—
—
0
0
11
17
6.81
6.85
1.7
1.4
—
—
—
0
0
12
21
6.03
6.67
1.4
1.3
53.2
1.4
u/ml
—
5
5
36
145
2.83
6.59
10.7
4.0
1.2
1.2
mmol/l
0.15
36
128
11
18
6.43
6.50
1.7
1.4
—
—
—
0
0
11
18
6.43
6.50
1.7
1.4
—
—
—
0
0
11
18
6.43
6.50
2.3
2.1
—
—
—
0
0
6
0
+∞
6.28
1.5
0.0
—
—
—
0
0
26
91
3.15
6.06
1.4
1.4
—
—
—
0
0
11
20
5.78
5.88
2.3
2.0
—
—
—
0
0
12
24
5.27
5.82
1.4
1.2
4.2
5.9
u/ml
—
6
9
176
1478
3.77
5.70
42.2
14.8
53.7
77.8
ml/min/173m2
20.24
161
1220
39
179
2.49
5.48
4.5
3.3
—
—
—
0
0
82
514
2.05
5.39
3.8
3.3
2342.1
1111.8
ng/l
1.93
72
423
14
35
4.24
5.27
1.6
1.3
—
—
—
0
0
5
0
+∞
5.23
1.8
0.0
—
—
—
0
0
9
9
10.42
5.08
3.2
1.4
—
—
—
0
0
15
41
3.89
5.03
3.7
2.2
117.3
127.4
g/l
—
9
28
23
84
2.98
4.99
7.4
4.0
57.4
47.3
%
1.52
23
84
9
10
9.38
4.84
1.1
1.4
—
—
—
0
0
13
33
4.16
4.80
4.1
2.7
14.5
16.1
%
—
8
17
71
442
1.97
4.62
13.3
3.9
0.0
0.0
estimate
0.00
35
159
7
5
14.46
4.61
1.0
1.0
1725.1
1489.8
miu/ml
—
7
5
129
991
1.95
4.35
4.0
3.2
52.4
49.7
u/l
0.12
123
909
15
46
3.46
4.29
1.8
1.6
—
—
—
0
0
17
59
3.07
4.01
12.2
3.9
8.7
8.9
kpa
0.16
17
52
13
38
3.60
3.98
1.2
1.2
—
—
—
0
0
10
24
4.34
3.94
1.2
1.2
—
—
—
0
0
9
15
6.24
3.86
6.8
2.5
—
—
—
0
0
89
624
1.81
3.85
6.2
4.0
46.7
35.3
ng/l
0.71
78
445
6
5
12.33
3.79
1.0
1.0
101.8
104.0
%
—
6
5
6
5
12.33
3.79
1.0
1.0
—
—
—
0
0
8
12
6.90
3.71
1.3
2.0
—
—
—
0
0
8
12
6.90
3.71
1.3
2.0
—
—
—
0
0
118
906
1.81
3.71
3.4
2.7
—
—
—
0
0
10
26
4.01
3.57
1.2
1.1
—
—
—
0
0
6
7
8.80
3.28
1.8
2.9
—
—
—
0
0
6
7
8.80
3.28
1.8
2.9
—
—
—
0
0
6
7
8.80
3.28
1.8
2.9
—
—
—
0
0
6
7
8.80
3.28
1.8
2.9
—
—
—
0
0
9
19
4.92
3.28
2.0
1.3
—
—
—
0
0
12
38
3.30
3.27
1.3
1.3
—
—
—
0
0
54
340
1.82
3.24
1.9
1.7
445.0
454.3
pmol/l
0.09
46
280
85
614
1.70
3.15
13.9
3.7
—
—
—
0
0
169
1489
2.28
3.13
6.0
4.2
1.3
1.3
mmol/l
0.94
162
1336
174
1552
2.53
3.13
6.6
4.8
4.4
4.6
mmol/l
2.20
169
1413
13
45
3.03
3.09
1.2
1.2
—
—
—
0
0
5
5
10.22
2.99
1.2
1.2
—
—
—
0
0
5
5
10.22
2.99
1.0
3.2
—
—
—
0
0
5
5
10.22
2.99
1.2
1.2
—
—
—
0
0
51
323
1.79
2.98
3.5
3.9
199.5
166.1
ng/l
0.13
45
259
7
13
5.54
2.89
6.7
4.7
—
—
—
0
0
12
42
2.98
2.80
1.1
1.1
—
—
—
0
0
5
6
8.51
2.76
2.0
3.0
—
—
—
0
0
5
6
8.51
2.76
1.2
1.3
—
—
—
0
0
5
6
8.51
2.76
2.0
3.0
—
—
—
0
0
5
6
8.51
2.76
2.0
3.0
—
—
—
0
0
5
6
8.51
2.76
1.2
1.3
—
—
—
0
0
14
55
2.67
2.68
1.5
1.4
—
—
—
0
0
142
1206
1.71
2.61
4.6
4.0
15.5
14.8
pmol/l
2.42
137
1070
5
7
7.30
2.56
1.4
1.3
203.8
106.3
iu/ml
—
5
7
7
16
4.50
2.50
1.9
2.3
—
—
—
0
0
7
16
4.50
2.50
1.9
2.3
—
—
—
0
0
7
16
4.50
2.50
1.9
2.3
—
—
—
0
0
53
356
1.68
2.48
1.5
1.3
0.5
1.7
u/ml
1.13
15
87
7
18
4.00
2.27
1.1
1.1
—
—
—
0
0
5
9
5.67
2.22
1.4
1.0
—
—
—
0
0
7
21
3.42
1.98
1.1
1.5
27.0
16.1
ug/l
—
7
21
8
27
3.05
1.96
7.3
3.2
—
—
—
0
0
5
11
4.64
1.95
1.4
1.2
—
—
—
0
0
5
11
4.64
1.95
1.0
1.0
—
—
—
0
0
6
19
3.23
1.67
1.0
1.3
—
—
—
0
0
6
19
3.23
1.67
1.0
1.3
—
—
—
0
0
6
19
3.23
1.67
1.0
1.3
—
—
—
0
0
6
19
3.23
1.67
1.0
1.3
—
—
—
0
0
6
19
3.23
1.67
1.0
1.3
—
—
—
0
0
5
14
3.64
1.62
1.6
2.2
—
—
—
0
0
5
14
3.64
1.62
1.0
1.3
—
—
—
0
0
5
14
3.64
1.62
1.6
1.1
—
—
—
0
0
5
14
3.64
1.62
1.6
1.1
—
—
—
0
0
148
1329
1.52
1.58
55.5
19.3
14.2
13.8
%
3.46
148
1313
160
1463
1.61
1.56
5.9
4.8
2.0
2.0
mu/l
0.02
155
1308
9
39
2.37
1.45
1.9
1.6
—
—
—
0
0
63
497
1.40
1.34
4.3
5.1
2.8
2.7
ug/l
0.04
53
439
8
36
2.28
1.26
2.0
1.1
3.4
4.1
mmol/l
—
8
31
5
20
2.54
1.16
1.6
1.5
—
—
—
0
0
33
252
1.38
0.84
1.8
1.6
—
—
—
0
0
151
1416
1.33
0.81
47.4
17.0
36.3
39.7
%
5.68
108
975
7
38
1.87
0.74
8.7
1.2
0.9
0.8
nmol/l
—
7
30
26
197
1.37
0.70
15.2
8.2
—
—
—
0
0
26
200
1.35
0.65
1.9
4.8
2.2
27.4
ug/l
0.64
19
168
10
65
1.57
0.56
1.2
1.2
—
—
—
0
0
6
37
1.64
0.56
1.2
1.6
—
—
—
0
0
10
66
1.54
0.53
1.2
1.2
—
—
—
0
0
46
401
1.19
0.44
3.0
4.5
26.7
20.9
%
1.42
27
201
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
5
34
1.48
0.40
1.0
1.1
21.5
21.7
u/l
—
5
27
6
45
1.34
0.34
1.2
1.5
—
—
—
0
0
6
86
0.69
0.34
1.5
1.0
—
—
—
0
0
159
1544
1.19
0.33
7.8
4.8
5.8
6.0
mmol/l
1.43
148
1397
8
108
0.73
0.30
1.3
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
10
88
1.14
0.08
1.2
1.3
—
—
—
0
0
12
108
1.12
0.07
2.3
1.9
—
—
—
0
0
11
102
1.08
0.03
1.6
1.3
191.7
174.6
iu/ml
—
5
41
15
146
1.03
0.00
4.1
3.3
561.7
183.2
ng/l
0.63
15
132
23
228
1.01
0.00
1.5
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
10
100
1.00
0.00
2.4
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
55.7
—
0
7
0
8
0.00
0.00
0.0
2.4
—
13.7
—
0
8
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.6
—
0.1
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_MICROPOLYANG and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_MICROPOLYANG | 2.749 [1.87, 4.04] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.51 |
During the follow-up period (1.1.1998 — 31.12.2019), 83 out of 398 females with M13_MICROPOLYANG died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_MICROPOLYANG | 2.227 [1.42, 3.48] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.08 |
During the follow-up period (1.1.1998 — 31.12.2019), 83 out of 278 males with M13_MICROPOLYANG died.
Mortality risk
Mortality risk for people of age
years, who have M13_MICROPOLYANG.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.3% | 0.427% |
| 5 | 1.814% | 2.869% |
| 10 | 4.159% | 6.919% |
| 15 | 8.407% | 12.425% |
| 20 | 14.379% | 21.206% |
Relationships between endpoints
↥Index endpoint: M13_MICROPOLYANG – Microscopic polyangiitis
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data